UC San Diego Health Implements New Treatments for Chronic Brain Bleeds

UC San Diego Health has become the first on the West Coast to utilize novel coil technology for chronic subdural hematoma and is an early adopter of a new FDA-approved liquid treatment for the same condition. These advancements offer expanded minimally invasive options for a growing neurosurgical disorder, particularly benefiting older adults. This marks a significant step in patient care for brain bleeds.